Utah Medical Products, Inc. (UTMD)

US — Healthcare Sector
Peers: KRMD  LMAT  MLAB  PDEX  PFIS  USLM  WINA 

Automate Your Wheel Strategy on UTMD

With Tiblio's Option Bot, you can configure your own wheel strategy including UTMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol UTMD
  • Rev/Share 11.4463
  • Book/Share 34.6501
  • PB 1.6046
  • Debt/Equity 0.0022
  • CurrentRatio 41.87
  • ROIC 0.0863

 

  • MktCap 180600476.0
  • FreeCF/Share 4.0825
  • PFCF 13.0416
  • PE 15.0227
  • Debt/Assets 0.0021
  • DivYield 0.0219
  • ROE 0.1053

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 1
  • DCF Score 5
  • P/B Score 1
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3%
UTMD
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Negative

Utah Medical's Q2 earnings decrease year over year on lower OEM sales and weak international demand, though cost controls helped cushion margins.

Read More
image for news UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3%
Utah Medical Products, Inc. Announces Quarterly Dividend
UTMD
Published: July 29, 2025 by: Accesswire
Sentiment: Neutral

SALT LAKE CITY, UT / ACCESS Newswire / July 29, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on October 2, 2025 to stockholders of record at the close of business on September 17, 2025. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.

Read More
image for news Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Q1 Earnings Drop 16% on Sales Slump, Stock Up 1%
UTMD
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Negative

UTMD's Q1 2025 earnings fall 16% amid weak OEM sales, FX pressures and higher taxes, despite lower litigation costs and a strong cash position.

Read More
image for news Utah Medical Q1 Earnings Drop 16% on Sales Slump, Stock Up 1%
Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open
UTMD
Published: April 16, 2025 by: Seeking Alpha
Sentiment: Positive

Utah Medical Products develops and manufactures medical devices focused on women's health, obstetrics, gynecology, and blood pressure monitoring. The company's stock price has declined due to a drop in sales from a key U.S. customer, weaker performance in international markets, and ongoing litigation. Despite recent challenges, the company has a consistent track record of profitability, a fortress balance sheet, and a disciplined capital allocator in the CEO.

Read More
image for news Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open

About Utah Medical Products, Inc. (UTMD)

  • IPO Date 1999-03-08
  • Website https://www.utahmed.com
  • Industry Medical - Instruments & Supplies
  • CEO Kevin L. Cornwell
  • Employees 155
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.